BRTHF(BRTHF)
BRTHF
No analyst ratings available
No analyst price targets available for BRTHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $976.64B | $1.00T | $1.04T | $1.10T | $1.13T |
| Low | $965.91B | $978.78B | $1.02T | $1.08T | $1.11T |
| High | $987.37B | $1.03T | $1.06T | $1.12T | $1.15T |
| EBITDA Avg | $137.34B | $133.49B | $148.60B | $181.40B | $195.31B |
| Low | $134.51B | $130.92B | $145.84B | $178.03B | $191.73B |
| High | $140.16B | $136.05B | $151.36B | $184.77B | $198.88B |
| EBIT Avg | $127.80B | $116.34B | $125.01B | $152.09B | $161.15B |
| Low | $124.98B | $113.78B | $122.25B | $148.72B | $157.57B |
| High | $130.63B | $118.91B | $127.77B | $155.46B | $164.72B |
| Net Income Avg | $89.26B | $81.11B | $87.27B | $106.51B | $112.95B |
| Low | $87.25B | $79.29B | $85.31B | $104.12B | $110.41B |
| High | $91.26B | $82.94B | $89.23B | $108.91B | $115.49B |
| EPS Avg | $353.02 | $320.81 | $345.17 | $421.27 | $446.73 |
| Low | $345.09 | $313.60 | $337.41 | $411.80 | $436.69 |
| High | $360.96 | $328.02 | $352.93 | $430.74 | $456.78 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $241.14B | $255.22B | $245.74B |
| Low | $231.58B | $250.39B | $241.09B |
| High | $250.70B | $260.05B | $250.39B |
| EBITDA Avg | $36.95B | — | — |
| Low | $36.35B | — | — |
| High | $37.56B | — | — |
| EBIT Avg | $24.98B | — | — |
| Low | $24.37B | — | — |
| High | $25.58B | — | — |
| Net Income Avg | $17.49B | — | — |
| Low | $17.06B | — | — |
| High | $17.92B | — | — |
| EPS Avg | $70.32 | — | — |
| Low | $68.59 | — | — |
| High | $72.05 | — | — |
| Analysts (Rev / EPS) | 2 / 1 | 1 / — | 1 / — |